Parents tired of repeated school shutdowns and quarantines felt relief when Pfizer asked the U.S. to approve its COVID-19 vaccine for kids ages 5 to 11. If regulators give the go-ahead, kids’ shots could begin within weeks.
Nine-year-old Audrey Moulder, who lives in the Philadelphia suburb of Drexel Hill, is looking forward to visiting her grandmother without worrying she will give the older woman COVID-19.
Heather Miller, a mother of four from Dexter, Maine, said she wants to wait for follow-up studies on the vaccine. “I’m not 100% against getting it eventually, but I kind of fall into the ‘not right now, wait and see’ category,” she said. “Some parents are all for it and getting it for peace of mind,” she said, “but the majority of parents I’ve talked to will not be getting it.”
On Oct. 26, an independent expert panel that advises the FDA will publicly debate the evidence. If the FDA authorizes emergency use of the kid-size doses, the Centers for Disease Control and Prevention will make a final decision, after hearing from its outside advisers.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Pfizer asks US to allow COVID shots for kids ages 5 to 11Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill, but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities.
Baca lebih lajut »
Pfizer Asks US To Allow COVID Shots For Kids Ages 5 To 11Pfizer is asking the U.S. government to allow use of its COVID-19 vaccine in children ages 5 to 11.
Baca lebih lajut »
Pfizer seeks FDA authorization of Covid-19 vaccine for children ages 5 to 11Pfizer and BioNTech said Thursday they are seeking US Food and Drug Administration emergency use authorization from for their Covid-19 vaccine for children ages 5 to 11.
Baca lebih lajut »